Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2007
11/01/2007WO2007124447A2 Use of chalcogenides for treating shock and other adverse conditions
11/01/2007WO2007124133A2 Methods and compositions based on shiga toxin type 1 protein
11/01/2007WO2007123779A2 Improved dosing and scheduling of oligomers
11/01/2007WO2007123777A2 Inhibition of hif-1 activation for anti-tumor and anti-inflammatory responses
11/01/2007WO2007123403A1 Improved treatment of cystic fibrosis
11/01/2007WO2007123269A1 Azolecarboxamide derivative
11/01/2007WO2007123234A1 Antiepileptic action enhancer
11/01/2007WO2007123225A1 Oxadiazolidinedione compound
11/01/2007WO2007123186A1 Pharmaceutical product
11/01/2007WO2007123126A1 Agent for improving decreased exercise tolerance in chronic heart failure
11/01/2007WO2007123044A1 Licorice polyphenol preparation
11/01/2007WO2007123010A1 Agent for improving bone metabolism
11/01/2007WO2007122981A1 COUMARIN COMPOUND CAPABLE OF INHIBITING INDUCIBLE NITROGEN MONOOXIDE SYNTHASE (iNOS)
11/01/2007WO2007122976A1 Therapeutic agent or development inhibitor of polyglutamine disease
11/01/2007WO2007122970A1 Ligand capable of binding to nuclear receptor
11/01/2007WO2007122956A1 Titanium oxide complex particle, dispersion solution of the particle, and process for production of the particle
11/01/2007WO2007122813A1 Solid preparation for oral application
11/01/2007WO2007122801A1 Gip secretion inhibitor
11/01/2007WO2007122756A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
11/01/2007WO2007092379A3 Sesamol derivatives as novel inhibitors of arachidonic acid formation
11/01/2007WO2007072503A3 Combinations for managing inflammation and associated disorders
11/01/2007WO2002090332A3 Novel aeylheteroalkylaminε derivatives
11/01/2007US20070255063 Benzothiazole- and benzooxazole-4,7-dione, derivatives and their use as cdc25 phosphate inhibitors
11/01/2007US20070255055 Epothilone derivatives
11/01/2007US20070254886 N-[5-bromo-3-({3-[2-(dimethylamino)ethoxy]-4-methoxybenzyl}oxy)pyridin-2-yl]-4-methylbenzenesulfonamide, used for prevention and/or treatment of infections, inflammatory and/or allergic diseases
11/01/2007US20070254877 Indole Derivative and Use for Treatment of Cancer
11/01/2007US20070254867 Heterocyclic Kinase Inhibitors
11/01/2007US20070254357 Gene therapy using replication competent targeted adenoviral vectors
11/01/2007US20070254297 KCNQ2 and KCNQ3 - potassium channel genes which are mutated in Benign Familial Neonatal Convulsions (BFNC) and other epilepsies
11/01/2007US20070254031 Rapidly disintegrable solid preparation
11/01/2007US20070254010 Methylene-containing copolymer of an unsaturated hydrocarbon monomer such as alpha-olefin, diolefin or cyclic olefin and an acrylic or vinyl monomer or having polyether, polylactone or polyester units; crosslinked with a radiation dose of at least 10,000 rads
11/01/2007US20070253980 New pharmaceutical composition from natural materials for regulating immunity, its preparation method and use
11/01/2007US20070253973 Fusion proteins comprising alpha fetoprotein
11/01/2007US20070253955 Methods for altering fertility
11/01/2007US20070253944 Use of creatine or creatine compounds for skin preservation
11/01/2007US20070253942 Lectin-directed prodrug delivery system
11/01/2007US20070253906 Identifying Amyloid precurser protein lowering agents; non-steroidal anti-inflammatory drug (NSAID); Alzheimer's disease
11/01/2007US20070253905 Abeta42 LOWERING AGENTS
11/01/2007US20070253896 7,9-Dihydro-Purin-8-One and Related Analogs as HSP90-Inhibitors
11/01/2007CA2650311A1 Improved treatment of cystic fibrosis
11/01/2007CA2650124A1 Oxadiazolidinedione compound
11/01/2007CA2649820A1 Agent for treating polyglutamine aggregation-caused disease or suppressing onset thereof
11/01/2007CA2649628A1 Pharmaceutical product
11/01/2007CA2649528A1 Therapeutic agent for allergy containing liposome having oligosaccharide on its surface
11/01/2007CA2649514A1 Licorice polyphenol preparation
11/01/2007CA2649043A1 Azolecarboxamide derivative
11/01/2007CA2646674A1 Use of chalcogenides for treating shock and other adverse conditions
10/2007
10/31/2007EP1849799A1 Modified virus capsid protein and the use thereof
10/31/2007EP1849797A2 Peptidomimetic protease inhibitors
10/31/2007EP1849782A1 Quinolinone derivatives as tyrosine kinase inhibitors
10/31/2007EP1849774A1 CYCLOHEPTA(b)PYRIDINE-3-CARBONYLGUANIDINE DERIVATIVE AND PHARMACEUTICAL PRODUCT CONTAINING SAME
10/31/2007EP1849760A1 Ether compounds, compositions, and uses thereof
10/31/2007EP1849478A2 Inflammatory mediator antagonists
10/31/2007EP1849477A1 Use of skin penetration enhancers and barrier disruption agents to enhance the transcutaneous immune response induced by ADP-ribosylating exotoxin
10/31/2007EP1849469A1 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
10/31/2007EP1849468A2 Pharmaceutical composition of a pde4 or a pde3/4 inhibitor and a histamine receptor antagonist
10/31/2007EP1848717A2 6-ether/thioether-purines as topoisomerase ii catalytic inhibitors and their use in therapy
10/31/2007EP1848438A2 Diaminophenothiazine compositions and uses thereof
10/31/2007EP1848433A2 Methods and compositions using 4-amino-2-(3-methyl-2,6-dioxopiperidin-3-yl)-isoindole-1-3-dione
10/31/2007EP1513821B1 Protein kinase inhibitors
10/31/2007EP1512402B1 Inhibitors against complex ii of electron transport system
10/31/2007EP1503760A4 Camptothecin derivatives and polymeric conjugates thereof
10/31/2007EP1496896A4 Inhibitors of akt activity
10/31/2007EP1470143B1 Compounds that inhibit factor xa activity
10/31/2007EP1448198B1 Nicotin-or isonicotin benzothiazole derivatives
10/31/2007EP1318980B1 Hydroxamate derivatives useful as deacetylase inhibitors
10/31/2007EP1289993B1 Caspase inhibitors and uses thereof
10/31/2007EP1242426B1 Gamma-hydroxy-2-(fluoroalkylaminocarbonyl)-1-piperazinepentanamides as hiv protease inhibitors
10/31/2007EP1192247B9 Sphingosine kinase enzyme
10/31/2007EP1153013B1 5-ht1f agonists
10/31/2007EP1144384B1 Compounds which inhibit leukocyte adhesion mediated by vla-4
10/31/2007EP1012320B1 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses
10/31/2007EP1012189B1 Treatment of obesity
10/31/2007EP0910564B1 D-amino acid derived inhibitors of cysteine and serine proteases
10/31/2007CN101065148A Conjugated complement cascade inhibitors
10/31/2007CN101062399A Decoction having functions of treating abdominal pain, diarrhea and so on
10/31/2007CN101062389A Prepared aconite root decoction for invigorating qi and blood
10/31/2007CN101062386A Ginseng ginger tea
10/31/2007CN101062326A Chinese traditional combination having anti-fatigue function
10/31/2007CN101062324A Coptis pill for removing external heat in body
10/31/2007CN101062306A White tiger ginseng decoction
10/31/2007CN101062237A Decoction for removing external heat in body
10/31/2007CN101062131A Chinese traditional medicine took orally by patients before induced abortion operation for preventing the postoperative complications
10/31/2007CN101062124A Shengyang pill for reducing excessive internal heat
10/31/2007CN101062117A Capsule for eliminating phlegm and relaxing heart
10/31/2007CN101062091A Southernwood decoction for preventing heatstroke
10/31/2007CN101062080A Medicinal composition for relieving fatigue and preparing process thereof
10/31/2007CN101062075A Wind-proof chuanxiong ginseng powder
10/31/2007CN101062053A Reduced toxicity cisplatin formulations and methods for using the same
10/31/2007CN101062035A Therapeutic combinations comprising amlodipin and atorvastatin
10/31/2007CN101061885A Method of producing body-strengthening type food made of agaric
10/31/2007CN101061840A Method of producing black bean ball having functions of strengthening kidney and bone
10/31/2007CN100345866C Compound for unstable dipeptidyl peptidase IV inhibitors
10/31/2007CN100345863C Estrieno[3,2-b]/[3,4-c]pyrrole derivatives useful as modulators of the estrogen receptors
10/31/2007CN100345847C Novel biarylcarboxamides
10/31/2007CN100345843C Derivatives of 4-(thio- or selenoxanthene-9-ylidene)-piperidine or acridine and its use as a selective 5-ht2b receptor antagonist
10/31/2007CN100345840C Stable hydrate of a muscarinic receptor antagonist
10/31/2007CN100345834C 异羟肟酸衍生物 Hydroxamic acid derivatives
10/31/2007CN100345833C Modulators of dopamine neurotransmission
10/31/2007CN100345830C Condensed heteroaryl derivatives
1 ... 313 314 315 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 ... 1564